基本信息
浏览量:134
职业迁徙
个人简介
Dr. Renato Mantegazza has a long-lasting experience in the field of Myasthenia Gravis (MG), Neuromuscular Junction Diseases (such as Lambert-Eaton Myasthenic Syndrome), Multiple Sclerosis and Inflammatory Myopathies by giving contributions in the understanding of the pathogenic mechanisms underlying these diseases and in their treatments. Dr. Mantegazza professional and scientific training has been developed at the Weizmann Institute of Science (Israel), Stanford University (USA). His scientific production consists of more than 190 peer-reviewed publications.
He is the Director of the Neuroimmunology and Neuromuscular Diseases Department at the Fondazione Istituto Neurologico "Carlo Besta" of Milan, the largest Italian Institution devoted to clinical and experimental neurosciences. The Neuroimmunology and Neuromuscular Diseases Department is dedicated to diagnostics, treatment and research of immune-mediated neurological diseases as well as neuromuscular/muscular disorders. It comprises a Therapeutic Hemapheretic Service, Diagnostic laboratories for Autoimmunity and Genetics, a Muscle Biopsy Unit and the Multiple Sclerosis Center. The Department also hosts biobanks for sera/plasma, muscle/myoblasts, thymus/thymic cell lines, peripheral blood mononuclear cells, fibroblasts, and nucleic acids from about 4500 patients affected by genetics, autoimmune, inflammatory diseases of the central and peripheral nervous system. Dr. Mantegazza has been recently appointed as the Director of the Clinical Research Department of the Istituto Neurologico "Carlo Besta" and acts himself as PI of several clinical trials in Multiple Sclerosis and Myasthenia Gravis. Dr. Renato Mantegazza is active in Scientific Advisory Boards of Biomarin, Alexion Pharmaceuticals, ARGX Pharma and TEVA Italia
研究兴趣
论文共 1 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
作者统计
#Papers: 0
#Citation: 0
H-Index: 0
G-Index: 0
Sociability: 0
Diversity: 0
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn